Document Type

Patent

Abstract

The invention relates to a method of suppressing B1 cell activity in a host (e.g., mammalian, including human) comprising administering to the host an effective amount of IL-12 that significantly suppresses or inhibits B1 cell activity. In addition, the invention relates to a method of treating a B1 cell disorder in a host, comprising administering to the host an effective therapeutic amount of IL-12. The invention further encompasses a method of screening for substances (e.g., proteins, peptides, small molecules) which enhance or suppress the inhibition of B1 cell activity by IL-12. The invention also relates to a substance identified by the methods of screening for a substance which enhances or suppresses IL-12 inhibition of B1 cell activity.

Patent Country

US

Patent Number

US5665347

Publication Date

9-9-1997

Assignee(s)

Genetics, Institute; Medical College of Ohio

Application Number

08/382658

Filing Date

February 1995

Primary Class

424/85.2

Secondary Class

514/3.8; 514/4.3; 514/7.3; 514/16.6; 514/17.5; 514/17.9; 514/19.6

Rights

These materials are free of copyright restrictions and are in the public domain within the United States only. The USPTO reserves the right to assert copyright protection internationally.

Institution

The University of Toledo

Repository

University of Toledo Libraries

Digital Publisher

Digital Initiatives

Share

COinS